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CHAPTER I 
INTRODUCTION 
Almost every clinical discipline in medicine has been 
influenced by the rapid advances of immunology in the past 
ten years. In. dentistry, the field of oral pathology 2nd 
periodontics have also undergone many important advances. 
It is time therefore that certain aspects of pulp biology 
and endodontics be considered in the light of immunobiology. 
The state of our scientific knowledge concerning inflammation 
of the dental pulp is at best empirical. Research shows 
most inflammation of the dental pulp is due to microorganisms 
or their metabolites, but no one has ever correlated this 
knowledge with the classical immunological concepts of in-
flammation. It is my contention that pulpal biology and 
pulpal inflammation should be examined in this manner. In 
order to begin, one must study the normal and compare it to 
the abnormal. It is the purpose of this study to select the 
pulps of normal healthy teeth and quantitate the major com-
ponents of their immunologic system, IgG, IgA, IgM, and com-
ponent C'3 of complement. Taking these results I will ad-
dress myself to unhealthy teeth with inflamed pulps and 
compare the values obtained. 
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CHAPTER II 
REVIEW OF THE LITERATURE 
A. Antibodies: Structure and Function 
lmmunoglobulins are protein molecules which function 
as specific antibodies and effect the humoral aspects of 
immunity. These proteins share many antigenic, structural, 
and biological similarities~ but differ in primary amino 
acid sequence permitting their antibody function to be 
highly specific. The history of gamma globulins is relat-
ively short, since Tiselius defined them with electrophoresis 
as recently as 1937. Just as electrophoresis served ini-
tially to distinguish gamma globulins from other serum pro-
teins, additional biochemical and immunochemical techniques 
made it clear that the gamma globulins were not a single 
group of proteins. Deutsch, et al (1946), showed most 
gamma globulins to have a molecular weight of about 160,000. 
Muller-Eberhard (1956), however, did ultracentrifugal studies 
which revealed approximately 10% of the gamma globulins in 
man are gamma macroglobulins, having a molecular weight of 
about 1,000,000 and a sedimentation rate of around 18s. 
At the other end of the scale, the Bence-Jones proteins 
I 
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were found to be microglobulins with molecular weights of 
about 20,000 - 50,000 and sediment cofiecients of 2-4 
(Svedberg and Pedersen, 1940; Rundles, ~ al, 1951; ten 
Thije, 1956;. and Putnam and Miyake, 1957). In 1963, Fahey 
and Lawrence, separated the serum proteins by electropho-
resis. The major fractions found were albumin and gamma 
globulins. The gamma globulins were further separated 
into a group of antigenically related proteins composed 
of three major groups: 6.6.s gamma globulin which com-
prises 71% of the total gamma globulin. e2A globulin which 
comprises 22% of the gamma globulins and YlM macroglobulins 
comprising approximately 7% of the total gamma globulin 
protein. The term gamma globulins is commonly used in a 
somewhat broader context to describe those serum proteins 
with antibody characteristics, which include the gamma 
globulins, but extend into the beta and alpha 2 range of 
electrophoretic mobility (Figure 1). The description and 
comparison of such immunoglobulins has been facilitated 
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by the adoption of a unified nomenclature summarized in 
Table 1. 
While studying rabbit immunoglobulins, Porter (1959) 
found that the gamma globulin molecule was too large to 
determine its function and relate function to its structure. 
He then carried out experiments degrading the molecule 
with crystal papain. This technique yielded three fragments 
y 
Figure 1 
Electrophoretic Pattern 
of Serum Immunoglobulins 
{:J 
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lgM 
lg A 
lg p 
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.TABLE I 
.Nomenclature of Immunoglobulins and Their Subunits 
Substance 
Immunoglobulins 
Papain fragments 
·chains 
Classes of heavy chain 
IgG 
IgA 
IgM 
IgD 
Types of light chain 
Recommended 
Nomenclature 
IgG or yG 
IgA oryA 
IgM or yM 
IgD or YD 
Fab 
Fe 
Fd 
F(ab ... ) 2 
Fab ... 
Heavy chain 
Light chain 
y Chain 
a. Chain 
µ Chain 
d Chain 
K or K chains 
L or A chains 
Adapted from, Clinical Immunology, 1971. 
Previous nomenclature 
y 2 ,yss~ 7Sy, 6.6 Sy 
Y1A, f3 A 
Y1 M, f3 2 M, 19y 
Y-macroglobulin 
.I , I I , A , C , S , 
III, B,F, 
A piece 
5 S divalent fragment 
Univalent fragment 
H, A 
L, BB 
I, B 
II, A 
1 
IJ1 
representing over 90% of the molecular weight. Frag-
ments 1 and 2 (subsequently called Fab) had a molecular 
weight of about 50,000 and retained the capacity to 
combine with antigens. Fragment 3 (subsequently called 
Fe had a molecular weight of approximately 80,000 and 
retained antigenic specificity. These facts lead him to 
believe that rabbit gamma globulin was composed of three 
fragments, two similar and one unique. Later studies 
elaborated in various texts .in the field (Clinical 
Immunology, Progress in Immunology), give further inform-
ation concerning the papain fragments. The Fe fragment 
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is a dimer of the C-terminal side of the heavy chain, and 
it contains most of the carbohydrate of the molecule but 
has no capacity to combine with antigen. Not withstanding, 
this fragment does have important biologic functions: it 
gives the antibody molecule the cap~city to fix complement, 
traverse the placenta or adhere to tissue mast cells. In 
addition, the Fab fragments retain antibody combining sites 
thus giving one molecule of antibody two combining sites. 
Further investigation in 1962 led Porter to propose 
a 4-chain polypeptide structure for antibody molecules. 
He found the molecule to consist of 2 heavy and 2 light 
chains covalently linked by interchain disulfide bonds. 
(Figure 2). 
Figure 2 
Porter Model of IgG 
Liglu Chains 
Fab 
\ . 
- I lc:n·~· Cham 
• DISULFIDE UOXD 
Fe 
Schematic drawing of yG globulin in T-shaped model. 
Each peptide chain is drawn as a continuous line, 
sud disulfide bonds are represented by O. Where 
intrachain bonds exist, the chain is drawn to form 
a loop. Extensive overall similarity is apparent 
in the placement of these loops between light and 
heavy chains and between the two portions of the 
heayy chain (adapted from Bellanti, 1972). 
7 
Fleischman, Porter, and Press (1963) confirmed the 
four chain arrangement with biochemical studies of the 
peptide chains in gamma globulins. This structure has 
been found to be applicable to all vertebrates having 
recognizable humoral antibody. 
B. The ~iological Properties ~ Immunoglobulins 
The biological properties of the immunoglobulins 
can be grouped into two categories: antigen binding and 
~iological functioning. Combination with the antigen is 
specific each molecule of antibody binding only to that 
particular specific antigen molecule for which it was 
produced. The other biological properties are independent 
of specificity and are common to all molecules of a 
given class of immunoglobulins. (See Table 2). 
In humans there are at least five major classes of 
immunoglobulins. These are, in order of description, IgG, 
IgA, IgM, IgD, and IgE. 
IgG has been defined in man as the one class con-
stituting the major proportion of serum immunoglobulins, 
immunochemically different from the other classes of 
immunoglobulins (Bernier, 1970; Bull. W.H.O., 1970). 
According to Barth (1964), IgG achieves a significant 
concentration in both vascular (appr~ximately 40% total 
8 
Mean 
Serum 
TABLE II 
Some Physical and Biologic Properties of 
Human Immunoglobulin Classes 
Con cen- Mean 
tration Molecular S Survival 
Class (mg/100 ml) Weight ___ 20,w Tf2 (q~y_s) Biologic Function 
yG or IgG 1240 
yA or IgA 280 
yM or IgM 120 
YD or IgD 3 
yE or IgE .03 
150,000 
170,000 
890,000 
150,000 
196,000 
Adapted from Bellanti, 1972. 
7 23 
7,10,14 6 
•. 
19 5 
7 2.8 
8 1.5 
1. Fix complement 
2. Cross placenta 
3. Heterocytotropic 
antibody 
1. Secretory antibody 
1. Fix complement 
2. Efficient agglutin-
ation 
? 
1. Reaginic antibody 
2. Homocytotropic 
antibody 
-., 
I 
'° 
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IgG), and extravascular (approximately 60% total IgG) 
fluids. He also demonstrated that this class of globulins 
has a relatively long half-life, approximating 23 days; 
As discussed by Bernier (1970), IgG molecules have the 
physiological ability to cross the placenta, thus aiding 
immunologic competence in the newborn infant. Further, 
this class is considered to provide the bulk of immunity 
in most infective diseases which feature blood born 
disemination, including bacteria, viruses, parasites, and 
fungi. 
IgA, originally called Beta-2A, was first described 
in human serum by Heremans (1959). He found this protein 
fraction to represent about one-sixth of the total immuno-
globulins. Reported concentration levels vary somewhat 
throughout the literature however, a recent study by 
Vaerman (1970), using the Mancini method (Mancini et al., 
1965), indicated the mean serum level to be 2.63 mg/ml. 
In 1963, Tomasi and Zigelbaum, found that IgA 
represented the main immunoglobulin in human exocrine 
secretions. Further examination also found concentrations 
of IgA in human milk, saliva, and tears, as well as fluids 
of the clostrum, and the respiratory, urinary, and gastro-
intestinal tracts. Later studies by Tomasi and Bienenstock 
(1968), showed IgA to have its highest concentration in the 
clostrum. Further, plasma cells in the intracellular 
spaces and blood vessels in and around the lining of 
secretory tracts seemed to be the main producers of IgA. 
These findings led Tomasi to conclusion that IgA 
11 
plays an important part in the regulation of the bacterial 
and viral flora of mucous membranes. Although human IgA 
possesses the same fundamental four-chain structure that 
is f~und in all immunoglobulins, it is unique with respect 
to the fact that its heavy chains tend to polymerize. This 
is especially noticable in IgA obtained from external sec-
retions, which regularly occurs as a dimer (Tomasi et al., 
1965). 
Historically IgM immunoglobulins were first recognized 
in the sera of cattle (Hridelberger and Pederson, 1937). 
Closer examination in 1956 by Muller-Eberhard using ultra-
centrifugation revealed that human serum had approximately 
10% of its gamma globulin fraction composed of gamma macro-
globulins with a molecular weight of around 1,000,000. 
Studies by Barth and associates (1964) showed IgM, due to 
its large size, is found mostly in the intervascular spaces 
and cannot pass the placenta. In 1967, Ishizaka and his 
colleagues, studied IgM and revealed many interesting 
properties. Due to its size IgM is a good agglutinator of 
particulate antigens, such as red blood cells or bacteria. 
12 
lgM also has the ability to fix complement but has a 
very low concentration in secretions. Structural studies 
carried out by Parkhouse, et al, (1970) demonstrated a 
pentamer shaped molecule made up of subunits remarkably 
similar to the four-chain structure described for IgG. 
This molecular structure undoubtly accounts for the physical 
properties related above. 
IgD is a class of immunoglobulins which have been 
lar~ely unexplored and as yet IgD has not been assigned a 
specific biological role. Rowe and Fahey (1965) in a 
description of a new class of immunoglobulins determined 
that increased concentrations of IgD are associated with 
chronic infections. Further examination of this class 
by Gleich (1969) showed IgD to have antibody activity but 
he could not define any specific properties. 
IgE represents a minor but distinct clas~ of immuno-
globulins present in the serum of man and higher primates. 
Concentration studies carried out by Johansson in 1967, 
and 1968 show healthy individuals to have mean concent-
rations below 1 mg/ml. However, IgE concentration can 
become elevated 2-30 times normal in various diseases, 
amoung which the atopic disorders and parasitic infestations 
appear to be most prominent (Johansson 1967; Hogarth-Scott 
~al., 1969). Another important property associated 
with IgE is its cytotrophic ability to bind mast cells 
and platelets as well as its ability to attach to homo-
logus skin. Thereby being closely associated with the 
anaphylatic reaction (Bellanti, 1972). 
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The function of an antibody is to combine with an 
antigen under physiological conditions. As noted pre-
viously the antibody combining sites are found on the Fab 
fragment but both the heavy and light chains of this mole-
cule are required for optimum antigenic reaction. Recent 
experimental observations have clearly shown that antibody 
specificty is determined by the distinctive amino acid 
sequence of the immunoglobulin polypeptide chains (Cohen 
and Milstein, 1967). Once an antibody has captured and 
combined with antigen, the immune response has begun. The 
immunological responses are classically divided into those 
mediated by humoral antibodies and those mediated by cells. 
In either case the most important aspect of the immune 
response is specificity. The characteristic of this 
specificity is the ability of the organism to recognize 
an antigen as foreign and to respond to it by the synthesis 
of specific reactive immunoglobins, mainly humoral anti-
bodies such as IgG or IgA, and/or the production of spe-
cifically synthesisized lymphocytes in the case of cell 
mediated ~mmunity. 
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C. Complement 
In light of what has been discussed about antibodies, 
it is necessary to include a description of another com-
ponent of the immune system: complement. The term com-
plement refers to a complex group of enzymes in normal 
blood serum that working together with antibodies play an 
important role as mediators of both immune and allergic 
reactions. Since the reactions in which complement are 
involved occur in blood serum or in other body fluids 
these are considered humoral reactions. 
As discussed in Frank's review article (1969), the 
discovery of complement came in the late 1800's. Its 
presence was noted during studies of the capacity of blood 
serum to kill certain microorganisms. Antibodies had 
been discovered a short time earlier, but it was found that 
their capacity to kill bacteria depended upon the action 
of· another constituent of serum namely alexin, or com-
plement. The terms were intended to indicate that the 
agent helps the antibody perform its defensive function. 
Although the term complement at first refered to an 
auxillary factor in serum, it is now known that in reality 
it is a complex enzyme system composed of nine functional 
entities comprised of eleven discrete proteins which 
together represent about 10% of the globulin fraction of 
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human serum (Muller-Eberhard, 1969). The nomenclature of 
complement was formulated by members of a complement work-
shop held in LaJolla, California in 1966. (Muller-
Eberhard, 1968). The individual complement components are 
designated by numbers and the entire system is represented 
sequentially in the following manner: C'l, C'4, C'2, C'3, 
e's, C'6, C'7, C'S, C'9. 
The complement sequence of reaction is normally 
triggered by the combination of an antibody and antigen. 
Humphrey and Dourmashkin (1965) ~oncluded that two or three, 
or perhaps only one, IgM molecule attached to a receptor 
on a sheep red cell could bring about lysis of the cell 
through complement activation, but that two adjacent mole-
cules of IgG wer~ necessary. They calculated that if the 
number of antigen sites on a sheep RBC was 600,000 and if 
lgG molecules attached at random, then approximately 1000 
molecules of IgG would be necessary to give, by chance, the 
occupation of two adjacent sites resulting in an activation 
of the complement system. 
·Normal IgG will more readily activate complement if 
heated to 63°C for 20 minutes. This process aggregates the 
IgG molecules and presumably is responsible for the act-
ivation of complement which has been observed when RBC's 
are exposed to serum at low ionic strength (Rapp and Borsos, 
16 
1963; Mollison and Polley, 1964). 
By aggregating different fragments of IgG it has been 
shown that the complement activation site is located on the 
Fe portion of the mol~cule (Muller-Eberhard, 1968). 
As was discussed earlier, not all immunoglobulins 
have the ability to fix complement. In the human system, 
IgG and IgM seem to have this ability with IgM molecules 
being far superior due to their pentameric shape (Ishizaka, 
et al, 1967). 
Some of the most important biological reactions associ-
ated with the complement system are the: (1) direct killing 
of cells, (2) enhanced phagocytosis of cells, (3) liberation 
of vasoactive substances. 
D. Direct Killing of Cells 
Green, Barrow, and Goldberg (1959) found that cells 
which have been acted upon by antibody and complement became 
permeable to small molecules, and they concluded that func-
tional holes had been formed in the cell membrane. Electron-
microscopy carried out by Dourmashkin, ~al (1962), 
demonstrated the presence of these holes. Furthermore, 
treatment of sheep RBC's with Forssman antibody and guinea-
pig complement produced holes with a diameter of 8 to 10 nm. 
Experiments described by Mollison (1969} showed the 
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production of holes in the cell membrane leads to loss of 
cellular osmotic control and subsequent rupture of the cell 
itself. 
E. The Enhancement of Phagocytosis 
Johnston, ·~al (1969), did experiments on enhancement 
of bacterial phagocytosis by serum. Using serum deficient 
in specific complement components and by sequential fixation 
of prurified human C'l, C'4, C'2, and C'3, it was shown that 
these four components, but not the latter-acting components, 
are necessary for optimal phagocytosis of pneumococci. This 
finding was similar to experimental data published by inves-
tigators for other bacteria (Stiffel et al, 1964; Glynn and 
Medhurst, 1967). Further studies by Cooper and Becker (1967) 
described how phagocytosis promoted by whole serum could be 
inhibited by the aromatic amino acid - containing peptides, 
glycyl-Tyrosine and glycyl-Leucyl-Tyrosine. From these 
findings they concluded that peptidase activity of C'3 
fixed to an immune complex is essential for phagocytosis. 
F. Release of Vasoactive Substances 
The activation of complement may produce anaphylatoxin 
which in turn liberates vasoactive substances from various 
cells. It is now known that the mediators of anaphylatoxin 
activity are substances with a molecular weight of approx-
r 
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imately 10,000 which are split off from C'3 and C'S 
(Cochrane and Muller-Eberhard, 1968). These substances 
liberate histamine from mast cells and, in rabbits, have 
been shown to liberate 5-hydroxytryptamine from platelets 
as well (Humphrey and Jaques, 1955). 
In incompatible blood .tranfusions in man, it is well 
known that symptoms such as a flushing of the face, and a 
constricting pain in the chest, as well as other phenomena 
are encountered only when the antibodies concerned are 
· er 
anti-A ~ anti-B, which are powerful complement activators 
(Mollison, 1969). It has been suggested that the liberation 
of vasoactive substance, during the complement reaction, may 
cause a slowing of the local circulation and help to isolate 
antigen-antibody complexes. (Mollison, 1969). 
G. Inflammatory Response 
Inflammation can be considered as a complex series 
of events which develops when the body is injured either 
by a physical or chemical agent, or by an autoimmune process. 
While there is a tendency in clinical medicine to consider 
the inflammatory response exclusively in terms of reactions 
harmful to the body, a more balanced view is that inflammation 
is essentially a protective response in which the body at-
tempts either to return itself to the preinjury condition 
or to repair itself after the inflicted injury. The 
19 
inflammatory response is an essential protective and rest-
orative function of the body as it attempts to maintain 
hemostasis in a changing and often adverse environment. 
H. Mediators 
For the past two decades, knowledge of acute inflam-
mation has slowly increased. In the 1950's, Spector and 
Willoughby investigated the apparent chemical mediators 
of ·the inflammatory process. These included histamine 
and 5-hydroxytryptamine. Their studies showed 5-hydroxy-
tryptamine to increase capillary permeability in the rat 
by approximately 100 times that of histamine. Further-
more, both chemicals were found to illicite pain upon 
injection, leading them to believe that these compounds 
could be responsible for the pain associated with inflam-
mation. 
Since 1965, there has been a new wave of interest 
concerning the acute inflammatory response~ For example, 
Houck, et al, in 1966, demonstrated that after tissue 
injury there is a modification of dermal collagenases, 
which lead to the formation df modified tissue proteins 
that can activate the complement system. Therefore, 
the initial mechanism for acute inflammation is thought 
to be the production of modified proteins, followed by 
20 
the activation of the complement system, which leads to 
the release of vasoactive substances. In experimental 
models of acute inflammation constructed by Willoughby, 
~ al, in 1960, it was shown that total depletion of 
hemolytic complement results in a depression of the acute 
inflammatory response. The involvement of complement 
in reactions other than immunologically mediated inflam-
mation has been confirmed by Hill and Ward (1971). They 
demonstrated that split fragments of C'3 are involved in 
experimental myocardial infarcts in rats. Further studies 
involving the effect of complement on inflammation show 
that activation of the complement system leads to the 
release of a number of vasoactive and phlogistic substances 
(eg. anaphylatoxin) by the third and fifth components of 
complement, which cause the release of histamine C567, 
a chemotactic polymorphonuclear substance (Cochrane and 
Muller-Eberhard, 1967). 
After release of vasoactive substances, the coagula-
tion system as described by Jancso, 1961, is activated. 
It is Jancso's opinion that the increased vascular per-
meability allows a coagulation process to occur on the 
terminal vessel walls (margination). _This further en-
chances vessel permeability and edema formation. Recently, 
Jancso's hypothesas has been confirmed by experiments 
carried out by Ward (1967). He demonstrated one of the 
clotting components, plasmin, yielding a split fragment 
of C'3 initiating chemotactic activity. 
More recently discovered mediators of inflammation 
are the prostaglandins. These are substances which are 
found during the latter stages of inflammation (Willis, 
1969, a and b). Giroud and Willoughby (1970) described 
these substances to be formed partly by the action of 
complement; in as much as their liberation depends on an 
intact complement system. 
21 
Experimentation with many nonsteroidal anti-inflam-
matory drugs shows inhibition of the release of the pros-
taglandins in vitro. (Vane 1971). Further studies by 
Smith and Willis (1971) showed aspirin therapy selectively 
inhibits prostaglandin production in human subject's 
platelets. DiRosa, Papadimitriou, and Willoughby (1972), 
have shown that the release of prostaglandins is closely 
associated with the migration of mononuclear cells into 
inflamed sites. They showed also that non-steroidal anti-
inflammatory drugs prevent phagocytosis and leukocyte 
migration in vitro. 
A traditional description of inflammation is given 
by Florey in his General Pathology text (1970). Generally 
three states of inflammation can be ~dentified. These 
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include, acute, subacute, and chronic, each has a typical 
histological description. The acute inflammatory response 
begins with the dilation of blood vessels and the ef-
fusion of leukocytes and fluids. The result of these 
processes leads to a loss of the normal capacity of blood 
vessels to retain fluids and cells, arriving at an edemic 
condition. Leukocytes are attracted by a localized 
synthesis of a chemotactic substance, while vascular 
permebility is altered by such mediators as histamine 
and 5-hydroxytryptamine. 
Within an hour of injury, polymorphonucler leuko-
cytes (PMN's) make their appearance. They can first be 
seen clustering along endothelial cells of vessels in 
the area of injury. This accumulation of cells along the 
vessel wall is called margination. Soon after this 
accumulation, these cells migrate and form the first line 
of defense against infection. Four or five hours later 
the mononuclear cells (lymphocytes and monocytes) appear, 
thus bringing more phagocytes (monocytes) and immunologic 
capacity via the lymphocytes to the area. Up to this 
point this description covers the protective aspects of 
acute inflammation, however, an uncontrolled inflammation 
can lead to severe abcess formations such as those 
described by Selzer and Bender in the text The Dental Pulp 
(1965). As they see it, an outpouring of too much 
fluid can build up sufficient intrapulpal pressure to 
cause irreversible damage to the connective tissue. 
Likewise, the arrival of excessive numbers of PMN's 
23 
and the subsequent discharge of their proteolytic enzymes 
Compromising problems such as these cause the 
tissue to pass through the subacute phase, which is an 
accumulation of lymphocytes and monocytes with formation 
of granulation tissue, into the chronic stage. Chronic 
inflammation is characterized by the continued presence 
of mononuclear cells with the appearance of plasma cells. 
The reason for a progession to this stage rather than a 
resolution of the inflammation is due to a persistance 
of foreign material, either viable or necrotic. Per-
sistance of these inflammatory cells can lead to severe 
functional impairment of a tissue either by immunologic-
ally mediated tissue injury or by a cummulating total 
fibrosis. 
In Bellanti's (1971) opinion, tissue injury due to 
immunologic reactions have their origin in the inflam-
matory response which is initiated by the reaction to 
antigens in tissue. The initiating event may be eith~r a 
mediator such as the leukotactic factor generated from 
the complement syst~m or a factor produced by the invading 
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microorganisms. Once the leukocyte has arrived from 
the blood stream, the inflammatory process is well 
under way and in many cases the process is accompanied 
by a variety of reactions. These ~athogenic effects of 
immune complexes are important contributors to a number 
of human diseases, pulpal pathology not withstanding. 
Generally, tissue injury produced by immune com-
plexes can be divided into four phases: (1) a combination 
of antigen and antibody and possibly complement producing 
complexes; (2) localization of complexes; (3) an accumu-
lation of humoral and cellular factors; and (4) the pro-
duction of tissue injury. The damage is generally a 
consequence of cellular interaction with the complexes 
and the neutrophil\ is the cell most clearly implicated 
I 
(Cochrane, 1967). 
I. Investigations Using Immunologic Assey 
The application of immunologic techiniques to clin-
ical medicine has seen dramatic increases in usage in the 
last 10 years. The basis for these tests lies in the fact 
that most clinical syndromes have changes in protein 
concentrations. By knowing which proteins are affected 
and what the normal serum values are, an investigator can 
use the various immunological reactions to quantitate 
these proteins. For example, in acute rheumatic endo-
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carditis, there are two main proteins of interest, C-
reactive protein (correlated with active tissue break 
down) and antistreptolysin O. In 1959, Fukuda, developed 
a gel diffusion technique for quantitating C-reactive 
protein in serum. Likewise, an accurate gel-diffusion 
test is available for quantitation of antistreptolysin 
O. Blum, ~ al, in 1970, found a negative ASO test to 
be significant and reliable as an indicator of insign-
~ficant ASO titer. 
Another area of interest for the application of 
immunologic assey is in neurological diseases. As 
described by Crawley (1969), there are four major cere-
brospinal fluid protein patterns seen in neurological 
disease. By analyzing the ratio of cerebrospinal fluid 
gamma globulin to total cerebralspinal fluid protein or 
to the ratio of gamma globulin to albumin one can deter-
mine if abnormalities exist (Hartley,~ al, 1966). 
Immunological studies have also been carried out 
concerning dental disease states.· Brill and Bronnestam 
(1960) carried out electrophoretic studies of gingival 
fluids recovered from human gingival pockets. They 
demonstrated gamma globulin in this fluid and hypothe-
sized the presence of antibodies as well. 
Analysis of biood serum from two hundred males, ages 
seventeen to twenty-two, was preformed by Shannon and 
Bibson (1964). They found no correlation between total 
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serum protein, albumin, globulin and periodontal disease. 
Brandtzaeg, in 1965, employing micro-double dif-
fusion tests developed by Ouchterlony (1949), determined 
that the proteins IgG, IgA, IgM, albumin and fibrinogen 
of gingival pocket fluid were present in proportion and 
in concentrations comparable to that of plasma. 
Byers (1973) studied the globulin fractions IgG, 
IgA, IgM of resected inflammed gingival tissue. Using 
low level immunodiffusion plates for the assay, he found 
glob~lin concentrations to be higher in inflamed tissue 
when compared to normal tissue, thus indicating to him 
the apparent localized production of immune globulins 
in gingiva. 
Extensive studies have also been carried out using 
a immunofluorescent technique to demonstrate increased 
globulin levels in gingival tissues. Brandtzaeg and 
Kraus (1965) reported dramatic differences between non-
inflamed and inflamed gingiva when studied with immuno-
fluoresence. They showed the ratio of IgA to IgG con-
taining plasma cells greatly increased- with inflammation. 
In 1970, Platt, Crosby, and Dalbrow used immunofluoresence 
to study gingivec\romized tissue from patients with 
r 
periodontal disease. Flourescing plasma cells for IgG 
and IgM seemed to be predominant with few recorded for 
IgA. The author's concluded that the host defensive 
mechanism provided by globulins persists through long 
periods of chronic inflammation. 
J. Pulpal Studies 
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As early as 1926, investigators were interested in 
the fluid content of teeth. Solutions of various stains 
such as trypan blue and india ink, were injected sub-
cutaneously into cats and dogs, and then the animals were 
sacrificed at various time intervals and their teeth 
sectioned for observation. In as short a time as 30 
minutes, color was perceived in the dentin, which became 
more intense with time. It was therefore concluded that 
the tubules present in dentin could be considered lymph 
channels where by nutrient materials, oxygen, and immune 
bodies are transported to the living dentin and the pro-
ducts of its catabolism are carried away. (Fish, 1926, 
1927 a and b). 
Von Kreudenstein (1958) employed a method of cutting 
away a goodly portion of the crown of a vital tooth with-
out exposing the dental pulp. A clear fluid was seen to 
appear on the surface on the dentin and was subsequently 
called "den tinliq uor'' 
r 
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Haldi, et al, in 1961, found by careful drilling 
access to the dental pulp without cellular damage could 
be obtained. By inserting a capillary tube into the 
l--c-~-vi~;--~-~ated a clear, colorless f 1 uid could be col-
lected. This was subsequently assayed. It was found that 
the protein content of the pulpal fluid was about one-fifth 
that of blood plasma, whereas the glucose concentration 
was in equilibrium with the concentrations in the arterial 
blood plasma. 
In a later study by Haldi and Wynn (1963), elec-
trop~oresis was done on pulp fluids obtained as described. 
These fluids were found to contain the same protein 
fractions as blood plasma, differing only in concentrations. 
It was suggested that the dental pulp fluid could be 
regarded as a capillary transudate. Further, it was their 
contention that globulin escapes more readily from cap-
illaries than does albumin. Likewise; proteins in the 
inflamed pulp show a much higher concentration than in 
the non-inflamed pulp, (Aono~ al, 1964). 
Meanwhile, in Japan, further pulp plasma protein 
studies were being carried out. As described by Honjo, 
1968, Sato and Yokomizo did electrophoresis on dental 
pulp homogenate. They found albumin, alpha, beta, and 
. . 
gamma globulin fractions in the supernatant. Honjo et al, 
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(1968, 1970) employed fluorescent antibody techniques 
to detect homologus plasma proteins in human pulp tissue. 
Using both inflamed and non-inflamed samples of dental 
pulp tissue, albumin, gamma globulin and fibrinogen 
were localized. In the inflamed specimens, a wider spread 
of stain was found depending on the amount of inflammati~n. 
Further, most of the immunoglobulin containing cells 
possessed IgG and very little IgA or IgM. This led them 
to believe that a local antibody production may occur in 
the dental pulp. 
It has been reported that if tissue components are 
damaged and/or modified by trauma, drugs or infection, 
they could be rendered antigenically active to the host, 
(Kaplan, 1958; Weigle, 1964). Moreover, as cited by 
Nishida (1971), Kimura reported a systemic allergic re-
sponse was induced as a result of sensitization with this 
type of modified tissue antigen, if retained over long 
periods of time within the tissue. This possibility has 
also been suggested for chronic dental foci (Dietz, 1952). 
Formaldehyde has been widely used to inactivate bacteria, 
viruses, and toxins while retaining their antigenicity. 
In addition, it has been claimed by some investigaters 
(Jacobs & Sommers, 1939) that the treatment of tissue 
components with"formaldehyde could render them antigenically 
r 
! 
30 
active to the host. In view of the possibility that 
tissues of the dental pulp treated with formalin could 
acquire antigenicity, with sensitization of the host, 
Nishida, ~ al, (1971) investigated antibody production 
to formalin treated rabbit dental pulp extracts and he 
found homologus antibodies in the IgG and IgM class by 
ultracentrifugation. 
The immune response has been proposed both as a 
mechanism of protection and as a mediator of injury. Immune 
globulins have been described in normal and inflamed human 
pupal tissue, but to this date, no accurate quantitation 
of their levels has been made. It is the design of this 
paper to compare the immunocompetance of inflamed and 
non-inflamed human pulp, by quantitation of IgG, IgA, IgM, 
C'3 factor of ~omplement and albumin. 
CHAPTER III 
MATERIALS AND METHODS 
Human dental pulps were obtained from teeth ex-
tracted in the oral surgery clinic at Loyola University 
Dental School. Teeth were catagorized as to inflamed 
and non-inflamed by the following criterion: non-inflamed 
teeth were those teeth with no caries or bone loss due 
to periodontial disease and assumed to be non-pathologic; 
inflamed teeth had carious exposures of apparent long 
term duration due to extensive destruction of tooth 
structure. Due to the small amount of tissue obtained 
from each tooth all pulps in each category were pooled. 
Eighteen subjects represented the non-inf lamed group 
ranging in age from thirteen to forty-eight years with a 
mean age of 24.3 years including seven males and eleven 
females, a total of thirty-three pulp samples were ob-
tained from this group (Fig. 5 ). Fourteen subjects 
participated in the inflamed group ranging in age from 
nineteen to sixty-eight years with a mean age of 38.9 
years, including 6 males and 8 females yielding thirty-one 
pulpal samples (Fig. 6 ). As well as extracting teeth from 
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the above patients, a finger prick blood sample was 
obtained for each patient and the serum pooled. Each 
patient contributed approximately 1/10 ml. of serum per 
tooth used in the study. All of the patients used for 
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this experiment were in good general health and were not 
presently taking any medication. The extraction pro-
ceedures were performed under local anesthetic employing 
regional blocks. 
Immediately after extraction each tooth was cracked 
by percussion with a mallet and the pulp was removed intact 
(see illustrations in appertdix). The pulpal tissue was 
examined macroscopically to determine the quality of the 
tissue, The inflamed samples were found to have localized 
abcess formation with some areas of intact pulp. The non-
inflamed specimens were totally intact with. no apparent 
pathology. All teeth which showed purulent pulps were not 
included in this study. The pulpal samples were promptly 
placed into a labeled serum bottle containing 1 ml. normal 
saline (0.85%) maintained in a crushed ice bath during 
the collection period. At the end of the collecting period 
the bottle was tightly stoppered with rubber stoppers and 
metal caps. The bottles were then placed into a Revco ultra 
low freezer at minus eighty-five degrees centigrade. 
The blood sample was collected in hematocrit tubes 
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and centrifuged for three minutes in a International 
micro capillary centrifuge. The serum fraction was 
decanted and stored in a small pyrex specimen bottle and 
maintained in a crushed ice bath during the collection 
period. At the end of the collecting period the serum 
samples were frozen and stored as above. 
After pulp samples were collected, saline extraction 
of the globulins was carried out. Sufficient dilutent 
as determined in a pilot study, was added to the samples. 
After dilution, the tissue was placed in a ground glass 
tissue homogenizer and maintained in a crushed ice bath 
during ten minutes of grinding. The resulting homogenate 
was placed in fifteen milliliter glass centrifuge tubes 
and centrifuged in a Beckman JA 20 centrifuge for thirty 
minutes at 20,000 R.P.M.'s at four degrees ~entigrade. The 
final volume of supernatant fluid was recorded. The straw 
colored supernatant fluid was pipetted off in three milli-
liter aliquots and placed in a 5-milliliter screw-cap 
Vac Vial. The liquid sample was then shell frozen in dry 
ice acetone mixture and placed on a lyophilizing manifold 
and maintained overnight until dry. The resulting powder 
samples were removed from the mainf old and held in a Revco 
freezer until needed. This proceedure was used for the 
pilot study samples, the inflamed pulp samples, and the 
r 
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non-inflamed•samples. 
The tissue extracts were assayed for immunoglobulins 
IgG, IgA, IgM, C'3 fraction of complement and albumin 
using regular and low-level immuno-plates. 1 Immuno-
plate immunodiffusion plates are used to quantitate a 
variety of proteins in serum and other body fluids. 
These proteins are of such a complex chemical nature that 
they have been difficult to identify or to differentiate 
by conventional chemical and electrophoretic techniques. 
By usual electrophoretic methods, serum proteins are class-
ified into groups designated as albumin, alpha1 globulins, 
alphaz globulins, beta globulins and gamma globulins (see 
Fig. 1, page 4 ). A number of protein fractions present 
in serum are not readily distinguishable by electrophoresis, 
usually due to overlapping mobilities. Immunodiffusion 
techniques are specific for identification and quantitation 
of those proteins for which specific ant~bodies have been 
developed. Proteins which presently have an immunological 
quantitation system include IgA, IgM, IgG, IgD, complement 
c'3, alpha2 macroglobulin and albumin. The immuno-plate 
utilizes a technique described by Fahey and McKelvey (1965) 
where an agar plate is prepared in corporating antibody 
throughout the agar. Six or twelve identically sized and 
1 
Hyland, Division Travenol Laboratories, Costa Mesa California. 
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positioned wells are prepared in the agar to receive the 
sample. The test sample is placed into the well and, on 
diffusion into the agar, forms a ring of antigen-antibody 
precipitate around the well. The diameter of the pre-
cipitate ring reflects the concentration of the antigen. 
Further, it was these author's opinion that this test could 
be used to quantitate proteins at a low concentration of 
3 mg% with a maximum of ± 10% error. 
One-half hour prior to assay the frozen lyophilized 
·samples were removed from the freezer and allowed to thaw 
at room temperature. Serial dilutions of standards were 
supplied by Hyland Laboratories in the following concen-
trations: IgG (320mg/100ml, 1000mg/100ml, 2000mg/100ml), 
IgA (67mg/100ml, 205mg/100ml, 430mg/100ml), IgM (40mg/100ml, 
120mg/100ml, 260mg/100ml), C1 3 complement (52mg/100ml, 
160mg/100ml, 32lmg/100ml), Albumin (13mg/100ml, 53mg/100ml, 
150mg/100ml, 330mg/100ml), low level IgG (3mg/100ml, 9.4mg/ 
lOOml, 43mg/100ml, 125.5mg/100ml) low level IgA (4.5mg/ 
lOOml, 10.5mg/100ml, 2lmg/100ml, 43mg/100ml), and low level 
IgM (3.75mg/100ml, 12.lmg/lOOml, 24mg/100ml, 49mg/100ml). 
These samples were placed on the immuno-plates in trip-
licate and incubated. After thawing the tissue samples 
were reconstituted with one milliliter of distilled, 
deionized water. The tissue samples and serum samples 
r 
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were then serially diluted with saline as follows: 1:2, 
1:4, 1:8, 1:16, 1:32. These dilutions and the concentrated 
samples were run in duplicate for all the tests mentioned 
previously. The plates were incubated at twenty-two 
degrees centigrade (room temperature) in 100% humidity. 
IgG, IgA, IgM C'3 fraction of complement, albumin, low 
level IgA, and low level IgM were incubated for 16 hours 
and read immediately. The low level IgG plate was in-
cubated for four hours and read. The precipitant ring 
diameters (F~g. 9) were measured with a caliper and milii-
meter measure to O.Smm., the plates being illuminated by 
the immunoilluminator.2 The mean diameters from the 
duplicate and triplicate runs were used for final deter-
minations. Protein levels were plotted on the Y-axis of semi 
log graph paper. Using the known serial dilutions, a 
standard curve for each protein fraction was drawn and the 
unknown protein concentrations were read from the standard 
curve (Figs. 10-16). 
2 . 
Hyland Laboratories, Costa Mesa, California. 
CHAPTER IV 
RESULTS 
The concentrations of immunoglobulin IgG, IgA, IgM, 
C'3 factor of complement, and albumin were determined for 
the ~ooled samples of non~inflamed pulp tissue, inflamed 
pulp tissue, serum samples from patients in the inflamed 
group, and serum samples for patients in the non-inflamed 
grou~. 
Comparing the serum samples of the inf lamed group to 
the non-inflamed group the following results were noted: 
1) mean concentration of IgG is comparable (1033 mg % to 
988 mg%); 2) the mean concentration of IgA seems to be 
approximately 2:1 (355 mg% to 192 mg%); 3) the mean con-
centration of lgM is also comparable (102 mg% to 167 mg%); 
the mean concentrations of albumin are comparable (3040 mg 
% to 3760 mg %), the mean concentration of C'3 complement 
is approximately 2:1 (211.6 mg% to 129.3 mg%). The 
mean protein levels for normal human serum as supplied by 
Hyland Laboratories are as follows: IgG 1200 mg %; lgA 
288 mg %; IgM 145 mg %; Albumin 4830 mg %; C'3 145 mg % 
(See Table 3). 
37 
,.. 
....... 
TABLE III 
Concentrations of Serum.Proteins 
Serum (mg per lOOml) 
C'3 
IgG IgA IgM Albumin Complement 
Inflamed 1033 355 102 3040 211. 6 
group 
Non-Inf lamed 988 192 167 3760 . 129.3 
group 
Pulp (mg per 100 ml) 
C 1 3 
IgG IgA IgM Albumin Complement 
Inf lamed 97.2 7.75 0 96 26 
group 
Non-Inflamed 47 4 0 111.3 23 
group 
Normal Human Serum (mg per ioo ml)3 
C'3 
IgG IgA IgM Albumin Complement 
1200±319 288±121 145±100 4830±900 145±22 
3 
Round Lake, Illinois Values supplied by Hyland Laboratories, 
variability of ±10% as per Fahey (1965). w 
00 
r 
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Comparing pulp concentrations, inflamed versus non-
inflamed, yielded these results: 1) the mean concentration 
of IgG was approximately 2:1 (97.2 mg % to 47 mg%); 2) 
the mean concentration of IgA also appeared to be approxi-
mately 2:1 (7.75 mg% to 4 mg%); 3) the concentration of 
IgM was not recordable; 4) the mean concentration of albumin 
was approximately the same (96 mg% to 111.3 mg%); 5) the 
mean concentration of C'3 complement is about the same (26 
mg% to 23 mg%) (See Table 4). 
A different view of the results can be achieved by 
comparing serum and pulp fluid concentration. By using 
the ratio of pulp protein to serum protein concentration 
the following figures are available: 1) the ratio of albumin 
in both inflamed and non-inflamed are identical (0.03); 
2) the ratio for IgG is approximately 2:1 inflamed versus 
non-inflamed (0.094 to 0.048); 3) values for IgM were not 
avaflable for pulpal samples; 4) IgA ratios were almost 
the same (0.022 to 0.021); 5) the ratio for C'3 complement 
are almost 1:2 inflamed versus non-inflamed (0.12 to 0.21) 
(See Table 4). 
Another method for analyzing the data was employed by 
comparing the ratio of protein concentration to albumin 
concentration. This analysis shows any increase or decrease 
TABLE IV 
Comparison of Serum and Pulp Fluid Concentrations 
Ratio of Pulp Protein to Serum Protein Concentrations 
Inflamed 
group 
Non-Inf lamed 
group 
Albumin IgG IgA C'3 Complement 
0.03 0.094 0.022 0.12 
0.03 0.048 0.021 0.21 
,i:.. 
0 
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as compared to albumin which is the marker protein in this 
study. It eliminates any increase in protein concentration 
due to serum volume increase. Comparison of the serum 
samples first, the ratio of inflamed versus non-inflamed: 
1) Albumin has a ratio of 1 to l; 2) IgG has a ratio of 
0.34 to 0.26; 3) IgA has a ratio of 0.12 to 0.05; 4) IgM 
has a ratio of 0.03.to 0.04; 5) complement has a ratio of 
0.07 to 0.03 (See Table 5). Examination of pulpal samples, 
inflamed versus non-inflamed, gives these results; 1) albumin 
has a ratio of 1 to l; 2) IgG has a ratio of 1.01 to .42; 
3) IgA has a ratio of 0.08 to 0.036; 4) IgM has no results; 
5) complement has a ratio of 0.27 to 0.21 (See Table 5). 
Graphic interpretation of these results can be ob-
tained by referring to figure 3 and 4. Standard curves 
plotted for calculation of unknawn protein concentrations 
are found in the appendix. 
,.. 
Serum 
Inflamed 
group 
Non-Inf lamed 
group 
Pulp 
Inflamed 
group 
Non-Inflamed 
group 
TABLE V 
Comparison of Immunoglobulins and Other Protein Components 
Ratio of Protein Component to Albumin 
Albumin IgG IgA IgM Complement 
1 0.34 0.12 0.03 0.07 
1 0.26 0.05 .04 0.03 
1 1.01 .08 0 0.21 
1 .42 .036 0 0.21 
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CHAPTER V 
DISCUSSION 
This study has shown that there is a marked increase 
in immunoglobulins IgG, IgA, and an apparent decrease in 
C'3 fraction of complement in inflamed pulpal tissue when 
compared to non-inflamed pulp tissue. The protein com-
ponents of the pulp tissue were saline extracted and assayed 
with immunodiffusion plates. Examining results of other 
tissue assay studies employing various immunologic tech-
niques, one finds demonstration of increased levels of 
immunoglobulins in inflamed tissue versus non-inflamed tissue. 
However, quantitation of these globulins was never in 
agreement (Byers; Brandtzaeg and Kraus; Platt, et al; Aono; 
Honjo). 
Utilizing the immunodif fusion technique for assaying 
tissue samples for serum protein quantitation offers a 
number of advantages. The antibody incorporated into each 
plate was specific for the protein to be evaluated. The 
plates demonstrated sufficient accuracy for routine clinical 
usage, furthermore, results were readily reproducible 
(Fahey, 1965). The immuno-plates offered a wide working 
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range when the low level plates were used in conjunction 
with regular plates; it was possible to detect protein 
concentrations as low as 3 mg percent. This quantitation 
technique appears to be superior to techniques employed by 
other authors in previous tissue assay studies. Elector-
phoresis studies while accurate in separating protein 
fractions of various electrophoretic mobilities, lack 
the ability to quantitate specific globulins or protein 
fractions. Only a mono-specific antibody-antigen reaction 
can accomplish this. Likewise, immunofluorescent are not 
always mono-specific which complicates accurate quantitation. 
For example, disaggregated collagen which is often found 
in inf lamed tissue will give a positive fluoresence for 
IgA and IgM. 
After examination of the mean concentrations of 
serum proteins in pulpal and serum samples certain trends 
were noted with regard to the concentration of IgG, IgA, 
and the C'3 fraction of complement. It appeared from this 
table that pulpal concentrations of IgG and IgA were approx-
imately 2:1 when comparing inflamed to non-inflamed (See 
Table 3). However, to fully utilize the serum marker pro-
tein, albumin, it was necessary to compare these figures 
differently. In table 4 a comparison was made between 
serum and pulp fluLd concentrations •. When looking at this 
r 
table, one can compare differences after equalizing any 
increase or decrease due to blood serum concentration. 
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The most interesting finding here is the relative decrease 
in C'3 complement concentration when comparing inflamed to 
non-inflamed samples. As can be noted by examining tables 
3 or 5 this difference does not appear. This is due to the 
fact that blood serum concentrations were not equalized in 
those figures. Further, table 3 and table 5 would lead 
one to believe complement should have been higher in the 
inflamed group as indicated by the level in the inflamed 
serum. However, the figures for pulps were similar due 
to the fact it was consumed in the inflamed condition. 
This decreased level of C'3 fraction of complement in inflamed 
ti~sues is confirmed by the experimentation reported by 
Cochrane and Muller-Eberhard, in 1967. 
The marked increase in immunoglobulin IgG and IgA 
in the inflamed pulp samples when compared to non-inflamed 
pulps is probably due to the antigenic stimulus of micro-
organisms in the pulp as well as the cellular breakdown 
products from the preceeding or ongoing inflammatory 
responses. Due to the unique environment of the dental pulp, 
the antigens and the toxic bacterial products are not readily 
accessable for removal by cleansing nor are they readily 
subject to dilution by the fluids of the Qral cavity. 
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Prolonged exposure to microorganisms may eventually break-
down the first lines of defense provided by the enamel 
and the dentin surrounding the dental pulp subsequently 
allowing the ingress of antigenic substances to the con-
nective tissues of the pulp. This could result in the 
mobilization of the immune system at the local and possibly 
the systemic level. Immunoglobulins specific for oral 
microorganisms have been demonstrated in serum antibody 
investigations (Mergenhagen, !:_!al, 1965). The increased 
level of immunoglobulins exhibited in this study could be 
due in part to a localized synthesis by local different-
iating immunocompetent cells or a production of immuno-
globulins by cells of the plasmacyte series which have 
migrated to the area. This could explain the presence 
of the large numbers of lymphocytes and plasma cells found 
when histologic sections of inflamed pulps are examined. 
This factor is usually not discussed when examining these 
microscopic sections. Most often it is noted that acute 
inflammation shows a predominance of PMN's and chronic 
inflammation shows an increased number of round cells. The 
immunocompetent cells of the dental pulp appear to synthesize 
antibodies in response to challenges from the antigenic 
capacities of microorganisms. However, these immunocompetent 
cells must continually synthesize immunoglobulins since the 
half-life of IgG is approximately 23 days and IgM and IgA 
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are much shorter (Barth 1964). 
The lack of findings for IgM in the pulp specimens 
can be accounted for with these arguments. In as much as 
all the inflamed pulp samples came from cariously exposed 
teeth one would expect to find long standing inflammation. 
The production of IgM is usually the first response to a 
antigenic challenge followed closely by that of IgG. The 
level of IgM peaks within a few days and further production 
seems to be inhibited by feedback mechanisms connected to 
the production levels of IgG. Also, the large pentameric 
molecule of IgM makes it susceptible to fractionization by 
the freeze-thaw method employed in this experiment. This 
could render the molecule antigenically inactive to the 
specific antibody on the immunodiffusion plates. 
There are some interesting clinical significances 
which can be deduced from this study. It is apparent from 
the increased levels of immunoglobulins that the pulp has 
the tissues and cells available to mobilize the immune 
response, whether the antigenic stimulus comes from micro-
organisms in the oral cavity or from cellular breakdown 
products. As was pointed out earlier, antibody titers do 
exist to normal oral flora. This means the first line of 
defense after the hard structures of th tooth are breached 
could be the circulating antibodies. Subsequently, an 
50 
arthus reaction could occur pulpally with circulating 
antibody complexing the foreign antigens and beginning_ 
the humoral as well as the cell mediated immune response, 
possibly leading to further tissue damage. It appears, 
therefore, that pulpal integrity could be destroyed by 
the loss of physiological function due to immunologically 
mediated tissue destruction as by acutal microbial invasion 
A traumatic incident could also effect the pulp by means 
of immunologically mediated tissue destruction. Locally 
damaged portions of the pulp due to a deep cavity pre-
paration, for example, could cause inflammation and sub-
sequent tissue breakdown as described eariler. If this 
inflammation and tissue destruction is not contained the 
entire pulp could become involved. This would allow the 
degradated products to penetrate the periapical tissue 
and possibly cause a lesion formation. A similar sequence 
of events could occur due to the presence of necrotic 
tissue in contact with viable tissue, dead tracts in dentin, 
necrotizing agents applied to dentin, or pulp stumps after 
pulpotomy are such examples. Kaplan (1958) and Dietz (1952) 
described that alteration of antigenic activity is possible 
when tissue components are damaged by long standing inflam-. 
mation, trauma, drugs, or infection. 
The pooling technique used in this study has weaknesses, 
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unfortunately the inherant size of the dental pulp makes 
individual samples impractical. The critism lies in the 
fact that pooling samples eliminates the possibility of 
reporting ranges in protein concentration and the fact that 
an extremely high or low sample will go undetected and 
could effect the mean substantially. 
The saline extraction of the examined for proteins 
could also lead to possibilities of error. Tissue fixed 
antibodies may have remained in the cellular debris after 
centrifugation which could mean the actual concentrations 
of antibodies may be even higher. 
It was necessary to assume advanced inflammation 
existed in the cariously exposed teeth as in sufficient 
material remained for each sample to make a histologic 
confirmation. 
Byer's studies (1973) did not include a marker 
protein such as albumin. Because of this he was unable 
to draw conclusions relative to the immunoglobulin con-
centration due to serum in the tissues. Both this study 
and Byer's work demonstrated increased globulin levels in 
their respective inflamed tissues. However, quantitative 
comparisons cannot be made due to differences in methodology. 
Further studies are necessary to more fully correlate 
the clinical observations with the histologic findings, 
and with the quantitative measure of the immunoglobulin 
and complement levels in the inflamed dental pulp. Work 
must also be directed to more clearly relate developing 
modern concepts of inflammation as they pertain to the 
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dental pulp. Future studies should include electronmicro-
scopy of the cellular components of the dental pulp during 
inflammation, studies of the antibody levels relating to 
specific antigens within the pulp, and possibly the use of 
immunofluorescent techniques. These studies would provide 
further insights into the mechanisms of response that 
pulpal tissue undergoes. 
CHAPTER VI 
SUMMARY AND CONCLUSION 
Human dental pulps were obtained from teeth extracted 
at the oral surgery clinic at Loyola University Dental 
School, for the purpose of assaying immunoglobulins IgG, 
IgA, IgM, C'3 fraction of complement and albumin. Teeth 
were catagorized as inflamed if they had carious exposures 
and non-inflamed if they had no caries or any bone loss due 
to periodontal disease. 
Eighteen subjects represented the non-inflamed group 
ranging in age from thirteen to forty-eight years, including 
seven males and eleven females. Fourteen subjects repre-
sented the inflamed group ranging in age from nineteen to 
sixty-eight years, including six males and eight females. 
Each patient also contributed approximately 1/10 ml of serum 
per tooth used in this study. Tissue specimens were pre-
pared and immunoglobulins, C'3 complement and albumin levels 
determined by immunodiffusion assay. 
The mean concentrations of IgG and IgA were greater 
in the inflamed samples than in the non-inflamed samples. 
J 
This indicates the apparent existance of an immune response 
in inflamed pulpal tissue with possibly localized synthesis 
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of immunoglobulins. 
The mean concentration of C'3 fraction of complement 
was shown to be markedly decreased in the inflamed sam~le 
versus the non-inflamed sample. This indicates that the 
inflammatory response existing in the inflamed group is 
utilizing C'3 complement. IgM was not demonstrated in 
the pulpal samples, indicating that IgM is not present in 
humari pulps in sufficient quantities to be detectable by 
the assay method employed in this study. 
The following conclusions can be made from this study: 
1) !gG, lgA, C'3 fraction of complement, and albumin are 
present in both inflamed and non-inflamed human dental 
pulp tissue. 
2) The mean concentration of IgG and IgA seem to be sub-
stantially higher in inflamed pulps when compared to 
non-inflamed pulps. 
3) The mean concentration of C'3 fraction of complement 
appears to be lower in inflamed pulp tissue when serum 
levels were consiqered and compared to non-inf lamed 
pulp tissue. 
4) IgM cannot be demonstrated in the human dental pulp 
with this assay technique. 
5) A local immune response appears to be occuring in 
inflamed dental pulps. 
55 
6) The saline extraction technique and immunodiffusion 
assay method used in this study are useful tools in 
quantitating the immunocompetence of the dental puip. 
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Figure #5 
Sample Distribution 
Non-Inflamed Group 
Age Teeth Selected Number of Blood Samples 
1. Male 14 4 Premolars 4 
2. Male 26 1 Molar 1 
3. Female 25 1 Molar 1 
4. Male 25 4 Premolars 4 
5. Male 23 1 Molar 1 
6. Male 17 1 Premolar 1 
7. Female 31 1 Molar 1 
8. Female 23 1 Molar 1 
9. Female 17 2 Molars 2 
10. Male 22 2 Molars 2 
11. Female 24 1 Molar 1 
12. Female 24 1 Molar 1 
13. Female 18 1 Premolar 1 
14. Female 48 2 Premolars 2 
15. Female 25 1 Molar 1 
16. Male 27 2 Premolars 2 
17. Female 13 2 Premolars 2 
18. Female 36 _!!.. Anteriors; 1 Premolar 4 
Total 33 
r 
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Figure 116 
Sample Distribution 
Inflamed Group 
Age Teeth Selected Number of Blood Samples 
1. Male 19 1 Molar 1 
2. Female 25 2 Molars 2 
3. Male 31 1 Molar 1 
4. Female 35 2 Molars 2 
5. Female 68 2 Premolars 2 
6. Female 23 2 Premolars; 3 Molars 5 
7. Female 22 1 MQ..lar 1 
8. Female 50 2 Molars 2 
9. Female 49 1 Premolar; 2 Molars 2 
10. Female 43 1 Molar 1 
11. Male 65 4 Premolars 4 
12. Male 43 1 Cuspid; 1 Molar 2 
13. Male 45 1 Premolar; 2 Molars 3 
14. Male 27 2 Molars 2 
Total 31 
Figure 7: Fracture Tooth Exposing 
Pulpal Contents 
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Figure 8: Pulpal Contents Extripated 
Figure 9: Demonstration of Precipitin Rings 
on Immunodiffusion Plates 
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Standard Curve for Low Level IgG 
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Standard Curve for Low Level lgA 
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Standard Curve for IgG 
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Standard Curve for IgA 
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Standard Curve for IgM 
•ing Diameter in Millimeters 
8 
75 
9 
... 
• 0 
0 
... 
-
eo 
• 
12 
0 
.,,( 
... 
.. 
2000 
1000 
:; 100 
d 
t> 
u 
d 
0 
u 
20 
• 
76 
Figure 15 
Standard Curve for Albumin 
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Figure 16 
Standard Curve for c•3 Complement 
•tna Diameter in Millimeters 
TABLE VI 
Commercial Lot Numbers For 
Immunodiffusion Plates 3 
Low Level IgA 
Low Level IgG 
Regular IgA 
Regular IgG 
Regular IgM 
Human Albumin 
Human C'3 Complement 
7092K002Al 
7072G003Bl 
7012GOOSA 
7005G008Fl 
7022G006Fl 
7102G001Cl 
7052G005Bl 
3Hyland Laboratories, Costa Mesa, California. 
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